Abstract:Gene therapy as an immunomodulatory approach has the potential to treat various inherited and acquired immune-based human diseases. However, its clinical application has several challenges, varying from the efficiency of gene transfer, control of gene expression, cell and tissue targeting, and safety concerns associated with the introduction of exogenous DNA into cells/tissues. Gene therapy is also a time- and labor-intensive procedure. As an alternative, we recently developed a novel technology, ProtEx, that allows for rapid, efficient, and durable display of exogenous proteins on the surface of cells, tissues, and organs without detectable toxicity. This technology exploits the strong binding affinity (Kd = 10(-15) M) of streptavidin with biotin and involves generation of chimeric molecules composed of the extracellular portions of immunological proteins of interest and a modified form of streptavidin, biotinylation of biological surfaces, and decoration of the modified surface with chimeric proteins. Biotin persists on the cell surface for weeks both in vitro and in vivo, thereby providing a platform to display exogenous proteins with extended cell surface kinetics. Two chimeric proteins, rat FasL (SA-FasL) and human CD80 (CD80-SA), were generated and tested for cell surface display and immunomodulatory functions. SA-FasL and CD80-SA molecules persisted on the surface of various cell types for extended periods, varying from days to weeks in vitro and in vivo. The cell surface kinetics, however, were protein and cell type dependent. SA-FasL showed potent apoptotic activity against Fas+ cells as a soluble protein or displayed on the cell surface and effectively blocked alloreactive responses. The display of CD80-SA on the surface of tumor cells, however, converted them into antigen-presenting cells for effective stimulation of autologous and allogeneic T-cell responses. ProtEx technology, therefore, represents a practical and effective alternative to DNA-based gene therapy for immunomodulation.

A Novel Recombinant Protein Tat-Gfp-Kdel with Dual-Function of Penetrating Cell Membrane and Locating at Endoplasm Reticulum

A Novel Recombinant Chemokine Protein TAT-SDF-1/54-KDEL for Blocking CXCR4: Bioinformatics Analysis and Prokaryotic Expression (CCR5P.263)

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

[Constructing the Recombinant of Pet28a-Tat-lacz].

Genetic Fusion of Transacting Activator of Transcription Peptide to Cyclized Green Fluorescence Protein Improves Stability, Intracellular Delivery, and Tumor Retention

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Phenotypic Knockout of CXCR4 by a Novel Recombinant Protein TAT/54R/KDEL Inhibits Tumors Metastasis

High-efficiency Protein Delivery into Transfection-Recalcitrant Cell Types.

[Preparation and characterization of Ad-ERα-36-Fc-GFP].

Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.

Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo

ProtEx: a novel technology to display exogenous proteins on the cell surface for immunomodulation

Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding

Characterization of the membrane penetration-enhancing peptide S19 derived from human syncytin-1 for the intracellular delivery of TAT-fused proteins

Protein transduction technology: a novel therapeutic perspective

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis

TAT-Mediated Protein Transduction of Nogo Extracellular Peptide 1-40 and Its Biological Activity

E3MPH16: An efficient endosomolytic peptide for intracellular protein delivery

Preparation of high-penetrability nano antibody fusion protein and application of high-penetrability nano antibody fusion protein in tumor resistance

Preparation and functional analysis of recombinant protein transduction domain-metallothionein fusion proteins